U.S. Corporations Face Reckoning Over Prescription Opioids, CEOs Keep Cashing In

Steve Collis, president and chief executive officer of AmerisourceBergen Corp., testifies during a House Energy and Commerce Subcommittee hearing on May 8, 2018.

Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.

(Image credit: Bloomberg/Getty Images)

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

6 TIPS TO ESTABLISHING & MAINTAINING BREASTMILK SUPPLY WITH A NEWBORN

GETTING BACK TO SCHOOL SAFELY